In conclusion, this study combines detailed clinical phenotyping with a comprehensive review of relevant germline ATM reports and large-scale tumor sequencing data to propose that germline pathogenic variants in ATM may be associated with the development of cancers of the gallbladder, duodenum, uterus, kidney, and lung as well as sarcoma cancers. This evidence concerns the gene ATM and cancer.